[A14-26] Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 17.11.2014
Commission awarded on 15.08.2014 by the Federal Joint Committee (G-BA).
Digestion, metabolism and hormones
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
|A16-12||Empagliflozin - Benefit assessment according to §35a Social Code Book V||Commission completed|
|A14-50||Addendum to Commission A14-26 (empagliflozin)||Commission completed|